2 Depressed Stocks Poised for a Long-Term Upswing: FVRR and MRNA

Investors scouring the market landscape for long-term opportunities may find potential in shares that have substantially retreated from their peaks. Two such stocks, belonging to companies that once enjoyed much rosier conditions, are Fiverr International Ltd. FVRR and Moderna, Inc. MRNA. Both have tumbled by 36% or more, yet they present compelling buy-and-hold cases for the next decade.

A Deep Dive into Fiverr International Ltd. FVRR

Operating a global online marketplace, FVRR provides freelance services across numerous sectors. Despite the stock's significant downturn, the Tel Aviv-based company boasts a versatile platform designed to meet the dynamic needs of the gig economy—a sector projected to grow exponentially. The flexibility and scalability of its business model might underpin a robust recovery and growth trajectory over the next ten years.

Understanding Moderna, Inc.'s Prospects MRNA

As a biotechnology leader, MRNA is at the forefront of developing messenger RNA-based vaccines and therapies. Their revolutionary approach to battling infectious diseases, among other medical challenges, positions MRNA well for long-term success. Although shares have taken a hit, the Cambridge-based company's innovation pipeline and expanding portfolio of treatments in various stages of clinical trials could trigger a substantial rebound and sustained growth in the coming decade.

investment, stocks, growth